☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
zymeworks
Zymeworks Reports the First Patient Dosing with ZW191 in P-I Study for Treating Folate Receptor-⍺ Expressing Advanced Solid Tumors
November 5, 2024
Zymeworks Reports the US FDA’s IND Clearance of ZW191 for Treating Solid Tumors
July 22, 2024
Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer
June 10, 2024
Top 20 Life Sciences Deals of 2022 by Total Deal Value
February 8, 2023
PharmaShots Weekly Snapshot (November 16-20, 2020)
November 20, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.